Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M0AM
|
||||
Former ID |
DAP001116
|
||||
Drug Name |
Glycopyrrolate
|
||||
Synonyms |
Asecryl; Copyrrolate; Cuvposa; Gastrodyn; Glycopyrronium; Nodapton; Robanul; Robinal; Robinul; Tarodyl; Tarodyn; Bromure de glycopyrronium; Bromure de ritropirronio; Bromure de ritropirronium; Bromuro de glicopirronio; Glycopyrrolate [USAN]; Glycopyrrolate bromide; Glycopyrroni bromidum; Glycopyrronii bromidum; Glycopyrronium bromide; ROBINUL FORTE; Ritropirronium bromide; Ritropirronium bromide [INN]; AHR 504; NVA 237; AD-237; AHR-504; Bromure de glycopyrronium [INN-French]; Bromuro de glicopirronio [INN-Spanish]; Glycopyrrolate (USP); Glycopyrronii bromidum [INN-Latin]; NVA-237; PT-001; Robinul (TN); Salt*); Glycopyrronium bromide (JAN/INN); Beta-1-Methyl-3-pyrrolidyl-alpha-cyclopentylmandelate methobromide; Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide; Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate; Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide; Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate; Mandelic acid, .alpha.-cyclopentyl-, ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide; Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate (8CI); Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate; (1,1-dimethylpyrrolidin-1-ium-3-yl)2-cyclopentyl-2-hydroxy-2-phenylacetate; (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromide; 1,1-Dimethyl-3-hydroxypyrrolidinium bromide .alpha.-cyclopentylmandelate;1,1-Dimethyl-3-hydroxypyrrolidinium bromide alpha-cyclopentylmandelate; 1-Methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate methobromide; 1-Methyl-3-pyrrolidyl alpha-phenylcyclopentaneglycolate methobromide; 3-(erythro-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidiniumbromid; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide-.alpha.-cyclopentylmandelate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticholinergic Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H28NO3+
|
||||
InChI |
InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1
|
||||
InChIKey |
ANGKOCUUWGHLCE-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 596-51-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
794727, 4582008, 7351415, 8152218, 11466774, 11467894, 11486407, 29222626, 46509133, 47275736, 47720778, 47869842, 48318623, 49699159, 50124171, 57321838, 80767354, 85209742, 103825408, 104234350, 104303677, 117554810, 124893611, 125081928, 127431325, 136023846, 137008742, 141652405, 141652414, 162108778, 162459186, 163366469, 163368548, 179150741, 184685744, 187051762, 224504317, 226501389, 246480751, 247320628
|
||||
SuperDrug ATC ID |
A03AB02; R03BB06
|
||||
SuperDrug CAS ID |
cas=000596510
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Antagonist | [535754], [536471] | |
References | |||||
Ref 538189 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040568. | ||||
Ref 542483 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7459). | ||||
Ref 535754 | A pharmacological profile of glycopyrrolate: interactions at the muscarinic acetylcholine receptor. Gen Pharmacol. 1992 Nov;23(6):1165-70. | ||||
Ref 536471 | Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther. 2008 May;83(5):692-701. Epub 2007 Aug 8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.